Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study
Authors
Keywords
-
Journal
Annals of Clinical and Translational Neurology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-09-03
DOI
10.1002/acn3.51446
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study)
- (2020) Steve Vucic et al. MEDICINE
- ALS is a multistep process in South Korean, Japanese, and Australian patients
- (2020) Steve Vucic et al. NEUROLOGY
- Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial
- (2020) William Camu et al. EBioMedicine
- Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis
- (2020) Sabrina Paganoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improving clinical trial outcomes in amyotrophic lateral sclerosis
- (2020) Matthew C. Kiernan et al. Nature Reviews Neurology
- Functional Biomarkers for Amyotrophic Lateral Sclerosis
- (2019) William Huynh et al. Frontiers in Neurology
- Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
- (2019) David R Beers et al. LANCET NEUROLOGY
- Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis
- (2019) Sudhir Kumar Yadav et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Amyotrophic lateral sclerosis as a multi-step process: an Australia population study
- (2019) Steve Vucic et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
- (2019) Jesus S. Mora et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Regulatory T cells for amyotrophic lateral sclerosis/motor neuron disease: A clinical and preclinical systematic review
- (2019) Misagh Rajabinejad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Following disease progression in motor neuron disorders with 3 MUNE methods
- (2018) Anna Bystrup Jacobsen et al. MUSCLE & NERVE
- Association of Regulatory T-Cell Expansion With Progression of Amyotrophic Lateral Sclerosis
- (2018) Rebecca K. Sheean et al. JAMA Neurology
- Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis
- (2018) Jason R. Thonhoff et al. CURRENT OPINION IN NEUROLOGY
- Cortical influences drive amyotrophic lateral sclerosis
- (2017) Andrew Eisen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- Urinary p75 ECD
- (2017) Stephanie R. Shepheard et al. NEUROLOGY
- Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications
- (2017) Jia Liu et al. Frontiers in Immunology
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
- (2011) David R. Beers et al. BRAIN
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
- (2010) David R. Beers et al. BRAIN BEHAVIOR AND IMMUNITY
- Electrodiagnostic criteria for diagnosis of ALS
- (2008) Mamede de Carvalho et al. CLINICAL NEUROPHYSIOLOGY
- CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS
- (2008) D. R. Beers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search